The Palico Private Equity Fund Marketplace
Third Rock Ventures is a private equity general partner firm headquartered in Boston, MA, United States and has other offices in
MA-based immuno-oncology company Neon Therapeutics has raised $70m in Series B from Partner Fund Management and others.
Revolution Medicines, which discovers and develops new drugs, has raised $25m in Series A extension from Column Group and others.
MA-based biotech company Goldfinch Bio has closed a $55m Series A round from Third Rock Ventures.
Read more news concerning Third Rock Ventures
A sampling of Third Rock Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?